Point72 Hong Kong’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,400
Closed -$66K 814
2023
Q4
$66K Buy
+2,400
New +$57.9K ﹤0.01% 510
2022
Q2
Sell
-1,214
Closed -$33K 2438
2022
Q1
$33K Buy
+1,214
New +$34.7K ﹤0.01% 1440
2021
Q4
Sell
-1,209
Closed -$56K 2425
2021
Q3
$56K Sell
1,209
-2,323
-66% -$101K ﹤0.01% 1497
2021
Q2
$141K Buy
3,532
+3,427
+3,264% +$147K ﹤0.01% 1239
2021
Q1
$6K Sell
105
-2,133
-95% -$123K ﹤0.01% 1644
2020
Q4
$110K Buy
+2,238
New +$104K 0.01% 1052
2018
Q4
Sell
-612
Closed -$6K 1219
2018
Q3
$6K Buy
+612
New +$6.75K ﹤0.01% 697

Other funds holding VCYT

Point72 Hong Kong's VCYT Position: Q1 2024 in Review

Point72 Hong Kong sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 2,400 shares — an estimated $66K sold.

Point72 Hong Kong first reported a position in VCYT in Q3 2018 and held it in 7 quarters. The position peaked at $141K in Q2 2021. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

  • Point72 Hong Kong reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 2,400 Veracyte shares in Q1 2024, an estimated $66K.
  • Point72 Hong Kong first reported a position in Veracyte in Q3 2018 and held it in 7 quarters.
  • Point72 Hong Kong's Veracyte position peaked at $141K in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.